Open AccessS697 Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease with Active or Recent Malignancy: A Multi-Center Cohort Study
Author(s) -
Ariela Holmer,
Jiyu Luo,
Sarah Park,
Jeong Yun Yang,
Vu Q. Nguyen,
M. Anthony Sofia,
Furkan U. Ertem,
Jeffrey Dueker,
Jessica C. Petrov,
Badr F. Al Bawardy,
Ernesto M. Llano,
David Fudman,
D. Joseph,
Sushrut Jangi,
Kirk Russ,
Nidah S. Khakoo,
Oriana M. Damas,
Edward L. Barnes,
Simon Hong,
Cameron Zenger,
Jordan E. Axelrad,
Frank I. Scott,
Msce,
Ryan C. Ungaro,
Siddharth Singh
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776320.54747.c3
Subject(s) - medicine , cohort , cancer , colorectal cancer , retrospective cohort study , vedolizumab , oncology , hazard ratio , population , cohort study , inflammatory bowel disease , disease , confidence interval , environmental health